Roche exec says COVID-hit health systems at 'more or less' normal capacity

ZURICH (Reuters) - Many patients have overcome initial fears of COVID-19 infections and resumed doctor visits, Roche's drug unit chief said, helping health systems even in hard-hit regions like Texas, Florida and California return to 'more or less' normal capacity. Swiss-based Roche's results this year have been dented as patients around the world shied away from hospitals and clinics during lockdowns, lowering demand for drugs including eye medicine Lucentis, multiple sclerosis drug Ocrevus and hemophilia medicine Hemlibra and leading to a 10% second-quarter sales decline. Bill Anderson, CEO of Roche's main pharmaceuticals unit with about $50 billion in annual sales, said in an interview on Tuesday that most of the world's health care systems have re-stabilized, 'even in places that had reasonably high levels of COVID'.

Reuters September 16, 2020 00:07:09 IST
Roche exec says COVID-hit health systems at 'more or less' normal capacity

Roche exec says COVIDhit health systems at more or less normal capacity

ZURICH (Reuters) - Many patients have overcome initial fears of COVID-19 infections and resumed doctor visits, Roche's drug unit chief said, helping health systems even in hard-hit regions like Texas, Florida and California return to "more or less" normal capacity.

Swiss-based Roche's results this year have been dented as patients around the world shied away from hospitals and clinics during lockdowns, lowering demand for drugs including eye medicine Lucentis, multiple sclerosis drug Ocrevus and hemophilia medicine Hemlibra and leading to a 10% second-quarter sales decline.

Bill Anderson, CEO of Roche's main pharmaceuticals unit with about $50 billion in annual sales, said in an interview on Tuesday that most of the world's health care systems have re-stabilized, "even in places that had reasonably high levels of COVID".

"In the month of August, you had places like Texas, Florida, California with a lot of infections," Anderson told Reuters.

"But we saw the health care system was more or less back at normal capacity. I think that was probably mostly a one-time thing, where people were really unsure, they were afraid to go out of the house, afraid to go to their family doctor, because maybe they would get COVID."

The public's understanding of risks has grown since the pandemic began, he added, boosting their confidence to move more freely.

Anderson's description of recovering demand underpins Roche move this summer to stick to its original 2020 forecast -- for full-year sales to grow in the low- to mid-single-digit percentage range -- despite the second-quarter revenue tumble.

Anderson did not give specific sales figures. Roche, which is expecting initial clinical trial data on the anti- COVID-19 drug it is developing with U.S.-based Regeneron this month, reports third-quarter sales on Oct. 15.

(Reporting by John Miller; Editing by Michael Shields)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

Danish Siddiqui's passing is a reminder of the high price one pays for showing the truth
India

Danish Siddiqui's passing is a reminder of the high price one pays for showing the truth

Danish's photographs were not just documentation, but the work of someone who went down to eye-level, as they say in photographic parlance.

Greek police clash with protesters in rally against mandatory vaccinations
World

Greek police clash with protesters in rally against mandatory vaccinations

ATHENS (Reuters) - Greek police used teargas and water cannon to disperse people who had gathered in central Athens on Saturday to protest against mandatory COVID-19 vaccinations. More than 4,000 people rallied outside the Greek parliament for a third time this month to oppose mandatory inoculations for some workers, such as healthcare and nursing staff.

Two Turkish soldiers killed in attack in northern Syria
World

Two Turkish soldiers killed in attack in northern Syria

ISTANBUL (Reuters) - Two Turkish soldiers were killed and two were wounded in an attack on their armoured vehicle in northern Syria, and Turkish forces immediately launched retaliatory fire, Turkey's defence ministry said on Saturday. "Our punitive fire against terrorist positions is continuing," the statement on Twitter on said. It did not specify where the attack occurred, but media reports said it was in the al-Bab area.